X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse FDC LTD. with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FDC LTD.   ADCOCK INGRAM
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ADCOCK INGRAM
Jun-14
FDC LTD./
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs144383-   
Low Rs79276-   
Sales per share (Unadj.) Rs47.6113.9-  
Earnings per share (Unadj.) Rs7.6-28.7-  
Cash flow per share (Unadj.) Rs9.0-23.8-  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.589.4-  
Shares outstanding (eoy) m177.83168.78-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.32.9 80.8%   
Avg P/E ratio x14.6-11.5 -127.3%  
P/CF ratio (eoy) x12.3-13.9 -89.1%  
Price / Book Value ratio x2.33.7 63.5%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,78455,608 35.6%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1,2213,490 35.0%   
Avg. sales/employee Rs ThNM4,476.9-  
Avg. wages/employee Rs ThNM813.0-  
Avg. net profit/employee Rs ThNM-1,128.1-  
INCOME DATA
Net Sales Rs m8,45919,219 44.0%  
Other income Rs m394135 292.4%   
Total revenues Rs m8,85219,354 45.7%   
Gross profit Rs m2,070-3,331 -62.2%  
Depreciation Rs m249829 30.0%   
Interest Rs m31521 6.0%   
Profit before tax Rs m2,184-4,546 -48.0%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606284 213.2%   
Profit after tax Rs m1,353-4,843 -27.9%  
Gross profit margin %24.5-17.3 -141.2%  
Effective tax rate %27.7-6.2 -443.8%   
Net profit margin %16.0-25.2 -63.5%  
BALANCE SHEET DATA
Current assets Rs m4,35514,076 30.9%   
Current liabilities Rs m1,7927,920 22.6%   
Net working cap to sales %30.332.0 94.6%  
Current ratio x2.41.8 136.8%  
Inventory Days Days44111 40.1%  
Debtors Days Days25124 19.9%  
Net fixed assets Rs m3,0258,205 36.9%   
Share capital Rs m17989 200.2%   
"Free" reserves Rs m8,2430-   
Net worth Rs m8,45315,085 56.0%   
Long term debt Rs m115,301 0.2%   
Total assets Rs m10,55728,497 37.0%  
Interest coverage x71.4-7.7 -923.6%   
Debt to equity ratio x00.4 0.4%  
Sales to assets ratio x0.80.7 118.8%   
Return on assets %13.1-15.2 -86.4%  
Return on equity %16.0-32.1 -49.9%  
Return on capital %23.5-19.8 -118.7%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Net fx Rs m7910-   
CASH FLOW
From Operations Rs m1,4851,640 90.5%  
From Investments Rs m-620-504 123.0%  
From Financial Activity Rs m-7534,811 -15.6%  
Net Cashflow Rs m1135,948 1.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.28 Rs / ZAR

Compare FDC LTD. With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare FDC LTD. With: GLENMARK PHARMA  CADILA HEALTHCARE  AJANTA PHARMA  FULFORD INDIA  NATCO PHARMA  



Today's Market

Sensex Surges 300 Points; Tata Steel Up 3.5%(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading near all-time high levels. Sectoral indices are trading on a positive note.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jan 23, 2018 01:33 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - ALKEM LABORATORIES COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS